Abstract:Evidence is reviewed that complementary proteins and peptides form complexes with increased antigenicity and/or autoimmunogenicity. Five case studies are highlighted: 1) diphtheria toxin-antitoxin (antibody), which induces immunity to the normally non-antigenic toxin, and autoimmune neuritis; 2) tryptophan peptide of myelin basic protein and muramyl dipeptide ("adjuvant peptide"), which form a complex that induces experimental allergic encephalomyelitis; 3) an insulin and glucagon complex that is far more antigenic than either component individually; 4) various causes of experimental autoimmune myocarditis such as C protein in combination with its antibody, or coxsackie B virus in combination with the coxsackie and adenovirus receptor; 5) influenza A virus haemagglutinin with the outer membrane protein of the Haemophilus influenzae, which increases antigenicity. Several mechanisms cooperate to alter immunogenicity. Complexation alters antigen processing, protecting the components against proteolysis, altering fragmentation and presenting novel antigens to the immune system. Complementary antigens induce complementary adaptive immune responses (complementary antibodies and/or T cell receptors) that produce circulating immune complexes (CIC). CIC stimulate innate immunity. Concurrently, complementary antigens stimulate multiple Toll-like receptors that synergize to over-produce cytokines, which further stimulate adaptive immunity. Thus innate and adaptive immunity form a positive feedback loop. If components of the complex mimic a host protein, then autoimmunity may result. Enhanced antigenicity for production of improved vaccines and/or therapeutic autoimmunity (e.g., against cancer cells) might be achieved by using information from antibody or TCR recognition sites to complement an antigen; by panning for complements in randomized peptide libraries; or using antisense peptide strategies to design complements.

Conversion of vaccines from low to high immunogenicity by antibodies with epitope complementarity

Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations

Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunization

Mechanisms that promote the evolution of cross-reactive antibodies upon vaccination with designed influenza immunogens

Modulating Antigen Availability in Lymphoid Organs to Shape the Humoral Immune Response to Vaccines

Molecular fate-mapping of serum antibody responses to repeat immunization

How to Make a Non-Antigenic Protein (Auto) Antigenic: Molecular Complementarity Alters Antigen Processing and Activates Adaptive-Innate Immunity Synergy.

Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology

Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon

Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against viruses

Diversity against adversity: How adaptive immunity evolves potent antibodies

From Therapeutic Antibodies to Immune Complex Vaccines

Vaccination against rapidly evolving pathogens and the entanglements of memory

A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms

Modeling the mechanisms of antibody mixtures in viral infections: the cases of sequential homologous and heterologous dengue infections

Vaccines combining slow delivery and follicle targeting of antigens increase germinal center B cell clonal diversity and clonal expansion

Increasing sensitivity of antibody-antigen interactions using photo-cross-linking

Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice

Systems Analysis Reveals High Genetic and Antigen-Driven Predetermination of Antibody Repertoires throughout B Cell Development

A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies